Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% sodium chloride----5件: 6, 14, 51, 53, 65 💬
20.9% sodium chloride injection----2件: 70, 168 💬
30.9% W/V sodium chloride solution----1件: 299 💬
4Dexmedetomidine
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
5Dexmedetomidine 1
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
6Dexmedetomidine 2
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
7Dexmedetomidine 3
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
8Dexmedetomidine group
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
9Dexmedetomidine HCL 100 MCG/ML INJ
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
10Dexmedetomidine hydrochloride
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
11Dexmedetomidine hydrochloride infusion
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
12Dexmedetomidine injection
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
13Dexmedetomidine with ropivacaine
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		2件: Dexmedetomidine,
Ropivacaine		4件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE),
Ropivacaine hydrochloride ,
Ropivacaine 💬 		8件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		7件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70 💬
14Fentanyl (LOW dose) + dexmedetomidine
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 215 💬
15Scopolamine, atropine, edaravone and dexmedetomidine
(DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE)		2件: Edaravone,
Scopolamine		2件: Scopolamine ,
Edaravone 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
16Sodium chloride
(0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE)		1件: Sodium chloride1件: Sodium chloride (0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE) 💬 --20件: 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
17Sodium chloride 0.9% INJ
(0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE)		1件: Sodium chloride1件: Sodium chloride (0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE) 💬 --1件: 298 💬
18Sodium chloride injection
(0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE)		1件: Sodium chloride1件: Sodium chloride (0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE) 💬 --1件: 226 💬
19Sodium chloride solution
(0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE)		1件: Sodium chloride1件: Sodium chloride (0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE) 💬 --4件: 11, 13, 51, 228 💬
20Sodium chloride solvent
(0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE)		1件: Sodium chloride1件: Sodium chloride (0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE) 💬 --1件: 228 💬
21Sodium nitroprusside
(SODIUM NITROPRUSSIDE IN 0.9% SODIUM CHLORIDE)		1件: Nitroprusside1件: Sodium nitroprusside (SODIUM NITROPRUSSIDE IN 0.9% SODIUM CHLORIDE) 💬 --1件: 51 💬
22Sodium pyruvate IN 0.9% sodium chloride solution----1件: 299 💬
23Solucion DE cloruro DE sodio sodium chloride solution
(0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE)		----1件: 228 💬
24Solvente cloruro DE sodio sodium chloride solvent
(0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE)		----1件: 228 💬
25Vasopressin
(VASOPRESSIN IN 0.9% SODIUM CHLORIDE)		1件: Vasopressin1件: Vasopressin (VASOPRESSIN IN 0.9% SODIUM CHLORIDE) 💬 3件: AVPR1A,
AVPR1B,
AVPR2 💬 		6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬2件: 210, 225 💬
26Vasopressin, arginine
(VASOPRESSIN IN 0.9% SODIUM CHLORIDE)		1件: Vasopressin1件: Vasopressin (VASOPRESSIN IN 0.9% SODIUM CHLORIDE) 💬 3件: AVPR1A,
AVPR1B,
AVPR2 💬 		6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 210 💬